TP53 and neoplasm: These include ribonucleotide-reductase/RR inhibition, redox-activity leading to the hydroxylation of benzoate and the degradation of DNA in the presence of Fe(II) and H2O2, down-regulation of cell cycle regulators, and activation of WAF (mediator of p53 tumor suppression) among other genes.